WILMINGTON, Del., Sept. 30 /PRNewswire/ -- ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, has named Ellen M. Derrico as its chief marketing executive in a move to expand the company's market development.
Prior to joining ParagonRx, Derrico served as interim vice president of business development, sales and marketing for P-Wave and as executive advisor and consultant to Acurian and NanoScan Imaging. She is founder, chair and member of the Greater Philadelphia Senior Executive Group (GPSEG) Life Sciences Subgroup and is on the Board of Advisors for ChemPharma® professional association.
"I am thrilled to welcome Ellen to our team," said Jeff Fetterman, CEO of ParagonRx. "She is a great fit with our company and our mission. With her varied experiences in life sciences companies at different stages of company growth, Ellen will be a tremendous asset to ParagonRx, especially at such an important time in our development."
"Joining ParagonRx is a great opportunity for me to help build this company, expand our markets and leverage experiences and best practices," Derrico said.
Derrico has held various global marketing executive and leadership roles with large and small life sciences companies including Hewlett-Packard (now Agilent Life Sciences), BioPort Corporation (now Emergent BioSolutions), Fast Track Systems (now Medidata Solutions), TriPath Imaging (now Becton Dickenson) and SAP Life Sciences Business Unit. Derrico began her career in pharmaceutical R&D with G.D. Searle (now Pfizer) and holds a Bachelors of Science degree in Chemistry from Purdue University and an M.B.A degree from Temple University, both with honors.
For more information, go to www.paragonrx.com.
Copyright©2009 PR Newswire.
All rights reserved